The Business Of Biotech Podcast
-
Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
10/29/2026
On this week's episode of the Business of Biotech, Edward (Ned) Patz, M.D., explains how a Duke University lab discovery turned into Grid Therapeutics and two clinical-stage cancer immunotherapy programs.
-
Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy
10/22/2026
On this week's episode of the Business of Biotech, Keith Murphy, CEO at Viscient Biosciences, unpacks how 3D human tissue models and scaffold-free bioprinting can change the way developers predict drug safety and model disease.
-
Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.
10/16/2026
On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug development and biotech investing.
-
AI, China, And Biotech Investing With SR One's Simeon George, M.D.
10/7/2026
On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech investment targets, and the good and bad signs that emerge during diligence.
-
Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
10/2/2026
On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using synthetic DNA switches and cancer-binding lipid nanoparticles to transform cancer cells into immune therapy-producing factories in vivo.
-
Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.
9/23/2026
On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted alpha therapies can unlock deeper, more durable cancer responses, and why radiopharmaceutical companies live or die by manufacturing.
-
Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D.
9/17/2026
On this week's episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s.
-
Biotech Finance And Investor Update With Independent Board Director Allan Shaw
9/9/2026
On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Allan Shaw returns to the show for an update on current biotech financing and the strategies needed to secure capital now.
-
Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig
9/3/2026
On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biotech playbook breaks down in today’s funding environment and what it takes to build a lean virtual drug development company without institutional financing.
-
Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka
8/26/2026
On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused, and survive the moments when biology and execution punch back.